EDTA/gelatin zymography method to identify C1s versus activated MMP-9 in plasma and immune complexes of patients with systemic lupus erythematosus.


Journal

Journal of cellular and molecular medicine
ISSN: 1582-4934
Titre abrégé: J Cell Mol Med
Pays: England
ID NLM: 101083777

Informations de publication

Date de publication:
01 2019
Historique:
received: 03 07 2018
revised: 11 09 2018
accepted: 20 09 2018
pubmed: 26 10 2018
medline: 16 4 2020
entrez: 26 10 2018
Statut: ppublish

Résumé

Gelatin zymography analysis is a sensitive method and commonly used to characterize and quantify the presence of the gelatinases (MMP-2 and MMP-9) in biological samples. In human plasma samples from healthy controls and systemic lupus erythematosus (SLE) patients, we observed a gelatinolytic molecule at 80 kDa, suggestive for activated human MMP-9. However, by developing and using the EDTA/gelatin zymography method and after purification of the 80 kDa entity, we proved that this molecule was the C1s subunit of the complement system. The zymolytic capacity of C1s was validated and found to be enhanced, in the absence of calcium and in the presence of EDTA. Our findings indicate that for correct identification of gelatinolytic proteins in complex biological samples the use of EDTA/gelatin zymography for enzyme development is advised. In addition, by quantification of EDTA/gelatin zymography analysis and ELISA, we observed that the levels of C1s were higher in plasma and immune complexes of SLE patients than of healthy individuals. Therefore, our data imply that C1s may become a marker for the diagnosis of SLE.

Identifiants

pubmed: 30358100
doi: 10.1111/jcmm.13962
pmc: PMC6307758
doi:

Substances chimiques

Antigen-Antibody Complex 0
Gelatin 9000-70-8
Edetic Acid 9G34HU7RV0
Gelatinases EC 3.4.24.-
Matrix Metalloproteinase 2 EC 3.4.24.24
Matrix Metalloproteinase 9 EC 3.4.24.35

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

576-585

Informations de copyright

© 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.

Références

Crit Rev Biochem Mol Biol. 2013 May-Jun;48(3):222-72
pubmed: 23547785
Immunobiology. 2002 Oct;206(4):368-76
pubmed: 12437068
Rheumatology (Oxford). 2000 Feb;39(2):133-41
pubmed: 10725062
Immunobiology. 1998 Aug;199(2):265-85
pubmed: 9777411
J Autoimmun. 2003 Jun;20(4):323-31
pubmed: 12791318
Nat Rev Dis Primers. 2016 Jun 16;2:16039
pubmed: 27306639
Arch Immunol Ther Exp (Warsz). 2001;49 Suppl 1:S41-6
pubmed: 11603868
Arthritis Rheum. 1974 Mar-Apr;17(2):121-8
pubmed: 4205506
J Cell Mol Med. 2019 Jan;23(1):576-585
pubmed: 30358100
Clin Biochem. 2008 Aug;41(12):955-9
pubmed: 18471998
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):986-991
pubmed: 28104818
Clin Exp Immunol. 1970 Aug;7(2):133-7
pubmed: 4991118
Nat Methods. 2013 Mar;10(3):211-20
pubmed: 23443633
Biochem J. 1983 Nov 15;216(2):385-92
pubmed: 6318736
J Biol Chem. 1999 Apr 2;274(14):9149-59
pubmed: 10092586
Front Immunol. 2016 Feb 24;7:55
pubmed: 26941740
Autoimmun Rev. 2008 Dec;8(2):160-4
pubmed: 18602499
Lancet. 2007 Feb 17;369(9561):587-96
pubmed: 17307106
Clin Exp Immunol. 2002 Feb;127(2):393-8
pubmed: 11876767
Semin Arthritis Rheum. 2004 Oct;34(2):501-37
pubmed: 15505768
Proc Natl Acad Sci U S A. 1990 Jul;87(14):5578-82
pubmed: 2164689
Arthritis Rheum. 1997 Sep;40(9):1725
pubmed: 9324032
Clin Exp Immunol. 1999 Apr;116(1):169-73
pubmed: 10209522
J Immunol. 1998 May 1;160(9):4641-7
pubmed: 9574573
Blood. 2004 May 15;103(10):3813-20
pubmed: 14726389
Cell Tissue Res. 2011 Jan;343(1):227-35
pubmed: 20838815
Rheumatology (Oxford). 2005 Oct;44(10):1227-32
pubmed: 15972354
Arthritis Rheum. 2004 Mar;50(3):858-65
pubmed: 15022328
Autoimmun Rev. 2008 Sep;7(8):612-5
pubmed: 18606253
J Clin Immunol. 2006 Jul;26(4):299-307
pubmed: 16652230
J Int Med Res. 2008 Jul-Aug;36(4):704-13
pubmed: 18652766

Auteurs

Estefania Ugarte-Berzal (E)

Laboratory of Immunobiology, Department of Microbiology and Immunology, Rega Institute for Medical Research, University of Leuven, KU Leuven, Leuven, Belgium.

Erik Martens (E)

Laboratory of Immunobiology, Department of Microbiology and Immunology, Rega Institute for Medical Research, University of Leuven, KU Leuven, Leuven, Belgium.

Lise Boon (L)

Laboratory of Immunobiology, Department of Microbiology and Immunology, Rega Institute for Medical Research, University of Leuven, KU Leuven, Leuven, Belgium.

Jennifer Vandooren (J)

Laboratory of Immunobiology, Department of Microbiology and Immunology, Rega Institute for Medical Research, University of Leuven, KU Leuven, Leuven, Belgium.

Daniel Blockmans (D)

Department of General Internal Medicine, University Hospital Gasthuisberg, KU Leuven, Leuven, Belgium.

Paul Proost (P)

Laboratory of Molecular Immunology, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.

Ghislain Opdenakker (G)

Laboratory of Immunobiology, Department of Microbiology and Immunology, Rega Institute for Medical Research, University of Leuven, KU Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH